SD Biosensor Statistics
Total Valuation
SD Biosensor has a market cap or net worth of KRW 882.79 billion. The enterprise value is 728.33 billion.
Important Dates
The next estimated earnings date is Saturday, November 21, 2026.
| Earnings Date | Nov 21, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
SD Biosensor has 119.62 million shares outstanding. The number of shares has decreased by -1.09% in one year.
| Current Share Class | 119.62M |
| Shares Outstanding | 119.62M |
| Shares Change (YoY) | -1.09% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 32.52% |
| Owned by Institutions (%) | 1.76% |
| Float | 32.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.19 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.81 |
| P/FCF Ratio | 79.32 |
| P/OCF Ratio | 15.56 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 15.45, with an EV/FCF ratio of 65.44.
| EV / Earnings | n/a |
| EV / Sales | 0.99 |
| EV / EBITDA | 15.45 |
| EV / EBIT | n/a |
| EV / FCF | 65.44 |
Financial Position
The company has a current ratio of 6.51, with a Debt / Equity ratio of 0.12.
| Current Ratio | 6.51 |
| Quick Ratio | 4.21 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 4.82 |
| Debt / FCF | 25.98 |
| Interest Coverage | -0.73 |
Financial Efficiency
Return on equity (ROE) is -26.90% and return on invested capital (ROIC) is -2.57%.
| Return on Equity (ROE) | -26.90% |
| Return on Assets (ROA) | -21.38% |
| Return on Invested Capital (ROIC) | -2.57% |
| Return on Capital Employed (ROCE) | -2.38% |
| Weighted Average Cost of Capital (WACC) | 12.32% |
| Revenue Per Employee | 1.20B |
| Profits Per Employee | -1.18B |
| Employee Count | 616 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 1.64 |
Taxes
| Income Tax | -63.58B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.09% in the last 52 weeks. The beta is 0.73, so SD Biosensor's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -18.09% |
| 50-Day Moving Average | 6,553.60 |
| 200-Day Moving Average | 7,222.85 |
| Relative Strength Index (RSI) | 63.35 |
| Average Volume (20 Days) | 146,751 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SD Biosensor had revenue of KRW 738.76 billion and -729.49 billion in losses. Loss per share was -6,098.16.
| Revenue | 738.76B |
| Gross Profit | 341.00B |
| Operating Income | -65.80B |
| Pretax Income | -794.66B |
| Net Income | -729.49B |
| EBITDA | 59.92B |
| EBIT | -65.80B |
| Loss Per Share | -6,098.16 |
Full Income Statement Balance Sheet
The company has 449.51 billion in cash and 289.12 billion in debt, with a net cash position of 160.40 billion or 1,340.88 per share.
| Cash & Cash Equivalents | 449.51B |
| Total Debt | 289.12B |
| Net Cash | 160.40B |
| Net Cash Per Share | 1,340.88 |
| Equity (Book Value) | 2.41T |
| Book Value Per Share | 20,062.20 |
| Working Capital | 773.01B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 56.74 billion and capital expenditures -45.61 billion, giving a free cash flow of 11.13 billion.
| Operating Cash Flow | 56.74B |
| Capital Expenditures | -45.61B |
| Depreciation & Amortization | 125.72B |
| Net Borrowing | -417.60B |
| Free Cash Flow | 11.13B |
| FCF Per Share | 93.04 |
Full Cash Flow Statement Margins
Gross margin is 46.16%, with operating and profit margins of -8.91% and -98.75%.
| Gross Margin | 46.16% |
| Operating Margin | -8.91% |
| Pretax Margin | -107.57% |
| Profit Margin | -98.75% |
| EBITDA Margin | 8.11% |
| EBIT Margin | -8.91% |
| FCF Margin | 1.51% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 2.71%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 2.71% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 214.97% |
| Buyback Yield | 1.09% |
| Shareholder Yield | 3.80% |
| Earnings Yield | -82.63% |
| FCF Yield | 1.26% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SD Biosensor has an Altman Z-Score of 2.47 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.47 |
| Piotroski F-Score | 4 |